Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma - Concepedia

Concepedia

Publication | Open Access

Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

DOI Full Paper Access

415

Citations

49

References

2004

Year

Steven M. Devine, Neal Flomenberg, David H. Vesole, Jane L. Liesveld, Daniel J. Weisdorf, Karin Badel, Gary Calandra, John F. DiPersio

Journal of Clinical Oncology

Abstract

AMD3100 appears to be a safe and effective agent for the rapid mobilization of CD34+ cells in patients who have received prior chemotherapy. Further studies in combination with granulocyte colony-stimulating factor in patients with lymphoid malignancies are warranted.

References

	Year	Citations

Page 1